<DOC>
	<DOCNO>NCT01877278</DOCNO>
	<brief_summary>The aim study evaluate efficacy wearable device use pulse electromagnetic field pain intensity reduction , measure visual analogue score ( VAS ) Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) , patient affect osteoarthritis Secondary aim evaluate effect knee effusion reduction , present evaluate pain intensity change correct pain threshold measure pressure algometry .</brief_summary>
	<brief_title>Wearable Pulsed Electromagnetic Fields Device Knee Osteoarthritis : Double Blinded , Randomized Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>diagnosis primary OA knee accord ACR criterion , include radiologic evidence OA age &gt; 40 year symptomatic disease least 6 month prior enrollment persistent pain despite receive maximum tolerated dos conventional medical therapy , include acetaminophen ( 4 gm/day ) and/or nonsteroidal antiinflammatory drug ( NSAID ) , persistent pain define minimum mean score 25 mm visual analog scale ( VAS ) global pain ( 0100mm range ) daily pain month prior study enrollment ability attend followup appointment secondary cause OA local systemic infection diabetes mellitus systemic arthritis allergy anesthetic agent contrast material coagulopathy anticoagulant therapy previous IA steroid injection avascular necrosis bone patient specific OA pharmacological therapy ( NSAIDS , opioids ) 2 week prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Pulsed electromagnetic field</keyword>
	<keyword>Device</keyword>
	<keyword>Pain</keyword>
	<keyword>Pressure algometry</keyword>
</DOC>